Return to Article Details
TARGETING THE SIGMA-1/NMDA RECEPTOR COMPLEX TO AMELIORATE COGNITIVE DEFICITS AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
Download
Download PDF